Teleflex (TFX) Set to Announce Earnings on Thursday

Teleflex (NYSE:TFX) will announce its earnings results before the market opens on Thursday, October 31st. Analysts expect the company to announce earnings of $3.38 per share for the quarter. Teleflex has set its FY24 guidance at $13.80-14.20 EPS and its FY 2024 guidance at 13.800-14.200 EPS.Parties interested in participating in the company’s conference call can do so using this link.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, August 1st. The medical technology company reported $3.42 EPS for the quarter, beating the consensus estimate of $3.33 by $0.09. The business had revenue of $749.70 million for the quarter, compared to analyst estimates of $762.98 million. Teleflex had a return on equity of 14.51% and a net margin of 8.76%. The company’s quarterly revenue was up .9% on a year-over-year basis. During the same quarter in the prior year, the company posted $3.41 EPS. On average, analysts expect Teleflex to post $14 EPS for the current fiscal year and $15 EPS for the next fiscal year.

Teleflex Stock Up 0.5 %

Shares of NYSE:TFX opened at $237.82 on Thursday. The business has a 50-day moving average price of $241.19 and a 200 day moving average price of $223.48. Teleflex has a 12-month low of $177.63 and a 12-month high of $257.85. The company has a current ratio of 2.58, a quick ratio of 1.44 and a debt-to-equity ratio of 0.36. The company has a market capitalization of $11.20 billion, a price-to-earnings ratio of 38.17, a PEG ratio of 2.18 and a beta of 1.16.

Teleflex Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, September 16th. Stockholders of record on Thursday, August 15th were paid a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.57%. The ex-dividend date was Thursday, August 15th. Teleflex’s dividend payout ratio (DPR) is 21.83%.

Insider Activity

In related news, Director Stuart A. Randle sold 2,674 shares of Teleflex stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $238.93, for a total value of $638,898.82. Following the completion of the transaction, the director now owns 5,496 shares in the company, valued at $1,313,159.28. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 1.43% of the company’s stock.

Analysts Set New Price Targets

TFX has been the subject of several research reports. Truist Financial lifted their target price on shares of Teleflex from $247.00 to $255.00 and gave the company a “hold” rating in a report on Monday, October 14th. Piper Sandler raised Teleflex from a “neutral” rating to an “overweight” rating and lifted their price objective for the company from $205.00 to $245.00 in a research note on Monday, July 1st. Stephens increased their target price on Teleflex from $275.00 to $290.00 and gave the stock an “overweight” rating in a research note on Friday, August 2nd. Finally, Royal Bank of Canada lifted their target price on Teleflex from $260.00 to $275.00 and gave the company an “outperform” rating in a research report on Tuesday, October 8th. Three research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Teleflex has an average rating of “Moderate Buy” and an average target price of $268.86.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.